Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

  1. Durán, C.E.
  2. Riera-Arnau, J.
  3. Abtahi, S.
  4. Pajouheshnia, R.
  5. Hoxhaj, V.
  6. Gamba, M.
  7. Alsina, E.
  8. Martin-Perez, M.
  9. Garcia-Poza, P.
  10. Llorente-Garcia, A.
  11. Gonzalez-Bermejo, D.
  12. Ibánez, L.
  13. Sabaté, M.
  14. Vidal, X.
  15. Ballarín, E.
  16. Sanfélix-Gimeno, G.
  17. Rodríguez-Bernal, C.
  18. Peiró, S.
  19. García-Sempere, A.
  20. Sanchez-Saez, F.
  21. Ientile, V.
  22. Ingrasciotta, Y.
  23. Guarneri, C.
  24. Tanaglia, M.
  25. Tari, M.
  26. Herings, R.
  27. Houben, E.
  28. Swart-Polinder, K.
  29. Holthuis, E.
  30. Huerta, C.
  31. Gini, R.
  32. Roberto, G.
  33. Bartolini, C.
  34. Paoletti, O.
  35. Limoncella, G.
  36. Girardi, A.
  37. Hyeraci, G.
  38. Andersen, M.
  39. Kristiansen, S.B.
  40. Hallgreen, C.E.
  41. Klungel, O.
  42. Sturkenboom, M.
  43. Montrer des auteurs +
Revue:
Frontiers in Pharmacology

ISSN: 1663-9812

Année de publication: 2023

Volumen: 14

Type: Article

DOI: 10.3389/FPHAR.2023.1207976 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus